Replies to post #208 on Astex Pharmaceuticals (ASTX)

[north40000]

Mike King views on ASTX buy-out courtesy of dough:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91720435

.....the proposed $8.50 per share offer from Otsuka is wholly inadequate considering the valuable collection of assets Astex has assembled.....

I thought buy-out price low myself, tho' I am in at $2.47.
I will await developments re competing bids, if any. I originally invested predicated in part re JNJ collaboration.